Last reviewed · How we verify
NCT03077139: CRT in PH
Cardiac Resynchronization Therapy in Pulmonary Hypertension
NA trial testing Cardiac Resynchronization Therapy (CRT) in Pulmonary Hypertension in 6 participants. Completed in 23 March 2017.
23 March 2017
Quick facts
| Lead sponsor | Dr. Daniel P Morin, MD MPH FHRS |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 6 |
| Start date | 29 November 2012 |
| Primary completion | 23 March 2017 |
| Estimated completion | 23 March 2017 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Cardiac Resynchronization Therapy (CRT)
Conditions studied
- Pulmonary Hypertension — all drugs for Pulmonary Hypertension →
Sponsor
Dr. Daniel P Morin, MD MPH FHRS
Who can join
Adults 18 to 75, any sex, with Pulmonary Hypertension. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study is being conducted to determine whether patients with advanced pulmonary hypertension when treated with cardiac resynchronization therapy improve hemodynamically and/or receive clinical benefit.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03077139
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Cardiac Resynchronization Therapy (CRT)
Trials testing the same drug.
- NCT03839121 — Safety and Performance Aspects of CRT-DX System in Patients With Sinus Rhythm · completed
- NCT03366545 — Observation of Clinical Routine Care for Heart Failure Patients Implanted With BIOTRONIK CRT Devices · active not recruiting
Other recruiting trials for Pulmonary Hypertension
Currently open trials in the same condition.
- NCT07179380 — Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension · Phase 3 · recruiting
- NCT07073820 — A Study to Learn About the Study Medicine (Called PF-07868489) in People With Pulmonary Arterial Hypertension Who Have P · Phase 2 · recruiting
- NCT06351345 — 129 Xenon Imaging in Patients Treated With Sotatercept · Phase 2 · recruiting
- NCT07187206 — Safety and Efficacy of FETO in CDH Phase III · Phase 3 · recruiting
- NCT07206173 — Londrina Activities of Daily Living Protocol in Pulmonary Hypertension · recruiting
Other Dr. Daniel P Morin, MD MPH FHRS trials
Trials by the same sponsor.
- NCT04539158 — Single vs. Dual-DCCV in Obese Patients · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03077139 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Dr. Daniel P Morin, MD MPH FHRS
- Last refreshed: 20 September 2017
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03077139.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing